Publication | Closed Access
A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months
12
Citations
16
References
2014
Year
Oseltamivir has a good tolerability profile in infants and children aged ≤24 months. These findings contributed to the recent FDA approval of oseltamivir for treating infants aged 2-51 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1